Can You Have Herpes Antibodies and Not Have Herpes?

Testing positive for herpes antibodies without ever having symptoms is common, but whether that means you “don’t have herpes” depends on what you mean by the question. In some cases, the antibodies are real and the virus is genuinely present in your body, lying dormant in nerve cells without ever producing noticeable outbreaks. In other cases, the test itself is wrong, and the antibodies it claims to detect aren’t actually there. Telling these two scenarios apart is harder than most people expect, and the distinction matters enormously for your peace of mind and your medical decisions.

Two Very Different Reasons for the Same Lab Result

When a blood test reports herpes antibodies, there are two broad explanations. The first is that you genuinely carry herpes simplex virus (HSV-1 or HSV-2) and your immune system has produced antibodies against it, but you’ve never noticed symptoms. This is asymptomatic infection, and it’s far more common than most people realize. The second is that the test gave a false-positive result, meaning the antibodies it detected either don’t exist or belong to a different virus entirely. Both situations leave you staring at the same positive result on a lab report, but they have very different implications for your health and your partners.

The challenge is that standard blood tests can’t easily distinguish between these two scenarios on their own. You typically need additional testing, clinical context, or both to figure out which category you fall into.

Asymptomatic Infection Is Extremely Common

Most people carrying HSV-2 have no idea they’re infected. A landmark study followed people who tested positive for HSV-2 antibodies by Western blot but reported no history of genital herpes. When researchers collected daily genital swabs, they isolated HSV from roughly 72 percent of these supposedly “asymptomatic” individuals. The rate at which they shed virus from their genital skin was virtually identical to that of people who did have a history of outbreaks.¹

A larger study reinforced this finding, showing that even among people with no recognized symptoms, genital HSV shedding occurred on about 10 percent of days. Nearly all of that shedding, around 84 percent, happened without any visible lesions or discomfort.² The virus was active on the skin surface without the person feeling anything at all.

So if your antibody test is accurate, the most likely explanation isn’t that you “don’t have herpes.” It’s that you do carry the virus but fall into the large group of people whose infections never produce recognizable symptoms. This is the most common scenario by a wide margin, and it’s worth understanding before jumping to the assumption that the test must be wrong.

When the Test Really Is Wrong

That said, false-positive results are a genuine and well-documented problem with herpes blood tests, especially for HSV-2. The tests most commonly ordered in clinical settings work by detecting antibodies to a viral protein called glycoprotein G. These tests are reasonably good at confirming that someone who has herpes does in fact have it, but they stumble when it comes to people who don’t, particularly when the numerical result falls in a murky zone.

Most commercial herpes blood tests report results as an “index value,” a number that indicates how strongly the test reacted. Values above 1.1 are typically called positive. But research consistently shows that low-positive values, those between roughly 1.1 and 3.0, are unreliable. A study evaluating a widely used automated testing platform found that about 21 percent of HSV-2 results with positive index values below 3.0 were actually false positives. For HSV-1 in that same low-positive range, the false-positive rate was even worse, reaching about 61 percent.³

This means that if your HSV-2 index value comes back at, say, 1.4, there is a real chance the result doesn’t reflect actual infection. The further below 3.0 the value sits, the less confidence anyone should place in it. Many clinicians and sexual health specialists now treat values in that low-positive range as essentially inconclusive, warranting follow-up testing before any conclusions are drawn.

Why the Tests Get It Wrong

Several factors contribute to false positives. One issue is cross-reactivity, where antibodies against related viruses trigger a reaction on the test. HSV-1 and HSV-2 are closely related to each other and share structural similarities with varicella-zoster virus, the pathogen that causes chickenpox and shingles. Research has shown that certain proteins on the varicella-zoster virus share an antigenic site with glycoprotein B found on both HSV-1 and HSV-2, meaning antibodies from a past chickenpox infection or shingles episode could theoretically confuse some assays.⁴ Modern type-specific tests based on glycoprotein G are designed to minimize this kind of cross-talk, but no assay is perfect.

Another source of confusion comes from herpes B virus, carried by macaques, which is closely related to HSV-1 and HSV-2. People who work with monkeys in laboratory or veterinary settings sometimes produce antibodies that cross-react on standard HSV tests. This is a niche scenario, but researchers have documented that the antigenic similarities between herpes B virus and HSV are responsible for false-positive diagnoses in human sera.⁵

Beyond cross-reactivity, the tests themselves show inconsistency. When researchers tested the same blood samples across multiple glycoprotein-G-based assays, they found that some people shifted from positive to negative depending on which test was used. These positive-to-negative shifts occurred in every assay tested, at rates ranging from about 6 to 21 percent of sample sets. There was only limited agreement among the assays about which individuals had lost reactivity.⁶ When different tests can’t agree on whether the same person is positive or negative, some of those positives are clearly wrong.

Antibodies from Someone Else’s Immune System

There is a scenario where you can genuinely have herpes antibodies circulating in your blood without ever having been infected: when those antibodies came from another person. This happens in two main situations.

The first involves intravenous immunoglobulin (IVIG) therapy, a treatment given to people with immune deficiencies and certain autoimmune conditions. IVIG is pooled from thousands of blood donors, and because herpes is so common in the general population, the pooled product contains antibodies against it. A study tracking patients before and after IVIG infusions found new positive results for HSV-1 and HSV-2 appearing after treatment, along with antibodies to several other infections the patients had never had. The researchers noted a dose-response pattern, where higher doses of IVIG led to more new false-positive detections.⁷ A separate report confirmed similar findings, with HSV-2 antibodies appearing in patients after IVIG infusions who had no history of infection.⁸

The second situation involves newborns. Mothers who carry HSV transfer their antibodies across the placenta during pregnancy. These maternal antibodies protect the baby during its first months of life but eventually fade. A newborn tested in the first weeks or months could show herpes antibodies that reflect the mother’s immune history rather than an actual infection in the child. Research in animal models has confirmed that this passive transfer of HSV-specific antibody persists even under stressful conditions and protects the newborn from HSV disease.⁹ These borrowed antibodies don’t mean the baby is infected.

What Happens When You Try to Confirm a Positive

The gold standard for confirming or refuting a positive herpes blood test has long been the Western blot, a more detailed laboratory test that looks at antibody responses to multiple viral proteins rather than just one. Western blot testing has historically been available through the University of Washington, and it’s considered far more accurate than the standard screening tests. Studies using Western blot as the reference standard to evaluate routine screening assays have consistently shown that a meaningful fraction of standard positive results turn out to be false.¹⁰

Confirmatory strategies that use a sequence of commercial tests before resorting to Western blot can improve accuracy while keeping costs down. Research evaluating these strategies has shown that running a second glycoprotein-G-based test on positive results, and sending only persistently discordant samples to Western blot, can achieve close to 100 percent sensitivity with a positive predictive value above 96 percent.¹¹ Newer multiplexed assays that check for antibodies against several HSV proteins simultaneously have also shown promise, achieving over 95 percent agreement with established methods and offering sensitivities and specificities in the mid-90s for both HSV-1 and HSV-2.¹²

If your screening test came back positive with a low index value and you’ve never had symptoms, pursuing confirmatory testing is a reasonable step. Many sexual health clinics and infectious disease specialists are familiar with this process. Some clinicians will simply recommend retesting with a different assay platform rather than jumping straight to Western blot.

False Negatives Are a Problem Too

The conversation around herpes antibody testing usually focuses on false positives, since those cause the most immediate anxiety. But it’s worth knowing that false negatives are also a real issue. Research studying patients with confirmed, recurring genital herpes lesions (proven by viral DNA testing from active sores) found that commercial type-specific antibody tests missed the infection in 12 to 30 percent of cases.¹³ These were people who definitely had herpes, with active viral shedding from lesions, and the blood test said they didn’t.

This happens partly because some people’s immune systems produce antibodies at levels too low for the test to detect, and partly because antibody levels can fluctuate over time. IgM tests, which are sometimes ordered to check for recent or acute infection, are even less reliable. Evaluations have found that single-type HSV-1 and HSV-2 IgM tests from major manufacturers did not reliably detect type-specific IgM antibodies.¹⁴ Most experts now advise against ordering IgM herpes tests altogether, as they often cause more confusion than they resolve.

Why Your Doctor Probably Didn’t Order This Test

If you’ve had a standard STI screening panel done, there’s a good chance herpes wasn’t included. This isn’t an oversight. The U.S. Preventive Services Task Force explicitly recommends against routine serologic screening for genital herpes in asymptomatic people. The reasoning centers on the poor accuracy of screening tests, particularly in populations where HSV-2 prevalence is relatively low, combined with the psychological harm of false-positive results and the uncertain benefit of starting antiviral medication in someone who has never had symptoms.¹⁵

The psychosocial fallout from a positive herpes test, even a correct one, can be substantial. A qualitative study of people with no history of genital herpes who tested positive on Western blot (so these were true positives, not false alarms) found strong emotional and psychological responses. Participants reported surprise, denial, distress, feelings of being “damaged goods,” fear about telling partners, sex avoidance, and concern about being socially stigmatized. Some of these responses faded with time, but others, like fear of disclosing to future partners, persisted.¹⁶ A systematic review examining this question noted that concerns about these negative psychosocial effects are one reason testing is not recommended for people without symptoms.¹⁷

The dilemma is real. Screening catches many genuinely infected people who could benefit from knowing their status, particularly to protect sexual partners or plan for pregnancy. But the same screening also delivers false positives that cause psychological harm and real positives that cause psychological harm in people who might have gone their entire lives without ever developing a symptom. Public health authorities have concluded that, on balance, the harms outweigh the benefits for routine screening of the general population.

How HSV-1 Antibodies Might Interact with HSV-2

One wrinkle that sometimes confuses test interpretation involves the relationship between the two herpes types. A person who carries HSV-1 (the type more commonly associated with cold sores, though it causes a growing share of genital infections too) may develop some degree of cross-protection against HSV-2. Population-level data suggest a negative association between the two infections: having HSV-1 antibodies appears to reduce the likelihood of acquiring HSV-2.¹⁸ Animal studies support the idea that pre-existing HSV-1 immunity provides a small but measurable survival benefit when challenged with HSV-2, though the protection is far from complete.¹⁹

This partial cross-protection can muddy things clinically. Someone with a strong HSV-1 antibody response might have a blunted HSV-2 antibody response if they acquire both viruses, making their HSV-2 test result weaker or harder to interpret. The interplay between the two types is one of the reasons herpes serology is more nuanced than a simple yes-or-no question.

What Vaccine Research Means for Antibody Interpretation

Herpes vaccine development adds another layer to the question. Several experimental vaccines are in various stages of testing, and people who participate in these trials develop herpes antibodies without carrying the virus. One trial of an investigational vaccine called HSV529, a replication-defective HSV-2 strain, showed that vaccinated people who were previously negative for both HSV types developed antibodies to several viral proteins, including detectable gD-specific antibodies in cervicovaginal fluid.²⁰ These individuals would likely show positive or equivocal results on certain serologic tests despite never having been naturally infected.

For now, this scenario affects very few people, since no herpes vaccine has reached the market. But as vaccine research progresses and larger trials enroll more participants, the possibility of vaccine-induced antibodies confusing future test results is something clinicians will need to track. Animal research continues to show that antibodies are essential for vaccine-induced protection against HSV-2, which means any successful future vaccine would necessarily generate detectable antibodies.²¹

Practical Steps If You’re Facing This Situation

If you’ve received a positive herpes antibody result and have never had symptoms, the single most useful piece of information is your index value. Ask your provider for the actual number, not just “positive” or “negative.” If the value falls between 1.1 and 3.5, particularly for HSV-2, a confirmatory test is warranted before drawing conclusions. Request either a Western blot or a second test using a different assay platform.

If the index value is well above 3.5 and you have no symptoms, the result is very likely accurate, meaning you carry the virus asymptomatically. This is not a medical emergency. You can discuss with your provider whether suppressive antiviral therapy makes sense for your situation, particularly if you have a partner who is HSV-negative or if you’re planning a pregnancy. Keep in mind that even without medication, many people with asymptomatic HSV-2 go their entire lives without a recognized outbreak.

If you’ve recently received IVIG therapy or a blood product transfusion, mention this to your provider, since the antibodies detected might have come from the donor pool rather than from your own immune system. If you work closely with nonhuman primates, that’s also worth mentioning, as cross-reactivity with herpes B virus can produce misleading results on standard HSV assays.

Finally, be cautious about IgM herpes testing. If a provider has ordered an IgM test and the result came back positive, treat it with skepticism. IgM tests for herpes are notoriously unreliable for distinguishing between types and for identifying new versus old infections. A positive IgM result in the absence of symptoms and without a confirmatory IgG test is close to meaningless in practical terms. Most sexual health experts consider IgM herpes testing more trouble than it’s worth.